Undergraduate education

University of Wisconsin-Madison, BS, 1994

Years in MSTP

1994-2000

PhD

Medical microbiology and immunology, 1998

Mentor

Gerald Byrne, PhD

Thesis title

Interactions Between Chlamydia Pneumoniae and Mononuclear Phagocytes in the Pathogenesis of Atherosclerosis

Residency

Ophthalmology, Harvard University

Fellowship

MBA, MIT School of Management

Current position

President and CEO, Cartesian Therapeutics

View profile

PhD publications

Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol. 2003 Apr;121(4):478-82. PMID: 12695244.

Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002 Dec 4;288(21):2724-31. PMID: 12460096.

Kalayoglu MV, Perkins BN, Byrne GI. Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect. 2001 Oct;3(12):963-9. PMID: 11580983.

Byrne GI, Skarlotos SI, Grunfeld C, Kalayoglu MV, Libby P, Saikku P, Summersgill JT, Wyrick P. Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. J Infect Dis. 2000 Jun;181 Suppl 3:S490-1. PMID: 10839745.

Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis. 2000 Jun;181 Suppl 3:S483-9. PMID: 10839744.

Mahdi OS, Byrne GI, Kalayoglu M. Emerging strategies in the diagnosis prevention and treatment of chlamydial infections. Expert Opinion on Therapeutic Patents. 2011 Aug;11(8):1253-1265.

Kalayoglu MV, Myint M, Byrne GI. Reply. J Infect Dis. 2000 May;181(5):1869-70. PMID: 10823810.